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ABSTRACT Clinical persistence of Chlamydia trachomatis (Ct) sexually transmitted
infections (STIs) is a major public health concern. In vitro persistence is known to de-
velop through interferon gamma (IFN-) induction of indoleamine 2,3-dioxygenase
(IDO), which catabolizes tryptophan, an essential amino acid for Ct replication. The
organism can recover from persistence by synthesizing tryptophan from indole, a
substrate for the enzyme tryptophan synthase. The majority of Ct strains, except for
reference strain B/TW-5/OT, contain an operon comprised of  and  subunits that
encode TrpA and TrpB, respectively, and form a functional  tetramer. However,
trpA mutations in ocular Ct strains, which are responsible for the blinding eye dis-
ease known as trachoma, abrogate tryptophan synthesis from indole. We examined
serial urogenital samples from a woman who had recurrent Ct infections over 4
years despite antibiotic treatment. The Ct isolates from each infection episode were
genome sequenced and analyzed for phenotypic, structural, and functional charac-
teristics. All isolates contained identical mutations in trpA and developed aberrant
bodies within intracellular inclusions, visualized by transmission electron microscopy,
even when supplemented with indole following IFN- treatment. Each isolate dis-
played an altered  structure, could not synthesize tryptophan from indole, and
had significantly lower trpBA expression but higher intracellular tryptophan levels
compared with those of reference Ct strain F/IC-Cal3. Our data indicate that emer-
gent mutations in the tryptophan operon, which were previously thought to be re-
stricted only to ocular Ct strains, likely resulted in in vivo persistence in the de-
scribed patient and represents a novel host-pathogen adaptive strategy for survival.
IMPORTANCE Chlamydia trachomatis (Ct) is the most common sexually transmitted
bacterium with more than 131 million cases occurring annually worldwide. Ct infec-
tions are often asymptomatic, persisting for many years despite treatment. In vitro
recovery from persistence occurs when indole is utilized by the organism’s trypto-
phan synthase to synthesize tryptophan, an essential amino acid for replication. Oc-
ular but not urogenital Ct strains contain mutations in the synthase that abrogate
tryptophan synthesis. Here, we discovered that the genomes of serial isolates from a
woman with recurrent, treated Ct STIs over many years were identical with a novel
synthase mutation. This likely allowed long-term in vivo persistence where active in-
fection resumed only when tryptophan became available. Our findings indicate an
emerging adaptive host-pathogen evolutionary strategy for survival in the urogenital
tract that will prompt the field to further explore chlamydial persistence, evaluate
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the genetics of mutant Ct strains and fitness within the host, and their implications
for disease pathogenesis.
KEYWORDS Chlamydia trachomatis, indole, interferon gamma, sexually transmitted
infections, trpA, tryptophan synthesis
Sexually transmitted Chlamydia trachomatis (Ct) infections are highly prevalent withestimates of more than 131 million global cases occurring annually (1). They
represent a major public health concern due to increasing rates worldwide and severe
complications of the female reproductive tract that include tubal factor infertility,
ectopic pregnancy, and chronic pelvic pain (2–4). Ct can also cause trachoma, a chronic
ocular infection that can lead to blindness (5, 6).
Sexually transmitted infections (STIs) with Ct can persist for long periods of time
(7–9). Most uncomplicated urogenital infections can be treated with a single dose of
azithromycin with an efficacy of 90% (10, 11). Paradoxically, treatment can also lead
to a subsequent increase in the rates of urogenital infections due to interference with
the development of effective immune defense against reinfection (12–14), known as
the arrested immunity hypothesis (15). In in vitro experiments, antibiotic treatment with
penicillin, rifampin, or azithromycin results in development of a persistent, nonreplica-
tive aberrant form of the organism that can recover on removal of the antibiotic (16,
17). This may be one explanation for the recent decrease in the clinical efficacy of
azithromycin (18–20).
Other factors can also cause in vitro persistence. In studies of human epithelial cells,
interferon gamma (IFN-) induces the indoleamine 2,3-dioxygenase (IDO) enzyme that
degrades tryptophan, an essential amino acid (aa) for Ct replication (21), and thereby
inhibits Ct growth, forcing the organism into a persistent state. Growth resumes when
tryptophan is added back to the medium (22, 23).
The genome of this obligate intracellular human pathogen has been shown to
contain a tryptophan synthase operon comprised of genes encoding the tryptophan
repressor (TrpR) and tryptophan synthase  and  subunits (TrpA and TrpB, respec-
tively) (24). Mutations in trpA were previously identified among trachoma strains A, Ba,
and C, suggesting that this gene is involved in organotropism (25). The mutations
resulted in a frameshift that was subsequently shown in vitro to render the enzyme
nonfunctional (24, 25).
Previously, the urogenital Ct TrpAwas found to be incapable of synthesizing indole from
indole-3-glycerol phosphate (IGP) (24). However, TrpB has been shown to catalyze trypto-
phan production from indole, which requires a full-length TrpA protein to form a proper
 tetramer with a tunnel for substrate binding and full synthase activity (26). Hence,
only Ct strains with an intact operon can be rescued in in vitro experiments when indole is
added back to the medium (25, 27, 28). However, it is conceivable that the organism could
undergo selective pressure in an IFN--rich environment, such as the urogenital tract, that
may promote advantageous mutations close to the active ligand-binding site of indole
and/or  and  subunit interaction sites. This could affect the structure and function of the
tetramer, resulting in establishment of persistent infections in vivo for long-term Ct survival,
although this has not been shown in human populations.
Here, we examined serial isolates of Ct urogenital F strains from a woman who had
had recurrent Ct STIs over a number of years despite antibiotic treatment. Our data
indicate that mutations in the tryptophan synthase operon of these urogenital strains
altered tetramer function and likely resulted in the in vivo persistence of the isolate in
the patient described, indicating a selective adaptive host-pathogen evolutionary
strategy for survival.
RESULTS
C. trachomatis clinical F strains I to IV contain a frameshift deletion mutation
causing trpA elongation and cluster as a phylogenetic subbranch of urogenital
strains. Clinical strains were isolated from a female who had recurring infections over
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a period of 4 years denoted F I to IV (F I-IV). The four strains had identical genomes
(GenBank accession no. SRA051574.1 [29]), suggesting persistent infection with the
same strain. ompA, a standard gene used for Ct genotyping, differed by a single
nucleotide polymorphism (SNP) from reference strain F/IC-Cal3, encoding a synony-
mous aa mutation. trpR and trpB sequences were identical to those of the reference
strain (Fig. 1A and B); trpA sequences contained a deletion at nucleotide (nt) 758,
compared with F/IC-Cal3, causing a nonsynonymous aa mutation, G253D, and elonga-
tion of TrpA by two aas (254N 255L) (Fig. 1C). These data were compared to the 20
known Ct reference strains, and none had this mutation.
Of seven novel San Francisco clinical F strains, F/SF10 was identical to D/UW3 and
K/UW31 at the N terminus and to E/Bour at the C terminus (Fig. 1C). F/SF14 was similar
to E/Bour, while F/SF21 was identical to K/UW31 and D/UW3 (Fig. 1C). Of the 59 publicly
available F sequences, F/HonMPB36 shared an identical trpA sequence with F/NL38 and
F/S4410, while trpR was truncated after 90 bp (Fig. 1A to C).
trpA phylogeny clustered F I-IV as a subbranch of F/IC-Cal3 (Fig. 2). The tree
differentiated ocular trachoma strains (A, Ba, C, and Da) from noninvasive urogenital
(D-K) and invasive lymphogranuloma venereum (L1-L3) strains, which is similar to
previous phylogenetic analyses of this gene. TrpA phylogeny was similar to trpA (see
Fig. S1 in the supplemental material).
Comparative structure analyses of TrpB and TrpA for clinical strains F I-IV
reveals mutations within the functional  tetrad complex. F I-IV TrpA was
elongated by two aas, 254N and 255L, to a total of 255 aas. Since there are no crystal
structures of the Ct tryptophan operon proteins, we used MODELLER (30) to model the
 and  subunits based on homologies to known crystal structure templates. The TrpA
structure (Fig. 3A, cyan) had 95% correct folds and a GA341 MODELLER score of 1.0,
indicating a highly reliable modeling structure (31), and aligned well with templates last
bacterial common ancestor (LBCA) 5ey5 (32), which had the highest identity to the
clinical F TrpA of 31.76% (Fig. 3A, magenta), Mycobacterium tuberculosis 5tch (28.63%
identity), and Salmonella enterica serotype Typhimurium 1qop (25.1% identity). The
elongation was located at the end of the protein (Fig. 3A and B, yellow surface of
ribbons), rather than at the active site. F/IC-Cal3 TrpA, which is known to be functional,
had good homology to the 5ey5 structure (32.02% identity) (Fig. 3C and D, yellow),
while A/HAR13 had 34.43% similarity for the 183 aas but only 23.07% similarity to the
entire 5ey5 protein (Fig. 3E and F; green).
Dimer subunits  and  have either an open or closed conformation. Closing of the
 subunit is associated with -loop L6 (-L6) mobility that requires residues 176 to
196 (Fig. 3B and D), which, together with the -COMM domain (Fig. 4A to C, bold
black), are critical for the closed conformation and formation of the tunnel that traps
indole (33). A/HAR13 has a predicted three-dimensional (3D) model that does not have
a complete -L6 (Fig. 3E and F, green) due to truncation at residue 183 in proximity to
the -COMM domain (Fig. 4C, black) and no proximal alpha helix (Fig. 3F, arrow).
Dimers for clinical F and F/IC-Cal3 had almost identical sequences and exhibited
comparable structures with95% correct folds (Fig. 4A and B) and a GA341 MODELLER
score of 1.0.
The TrpA aa alignment of F/IC-Cal3, A/HAR13, and F I-IV along with templates 5ey5,
5tch, and 1qop are shown in Fig. 5A. Highlighted in magenta are residues located
around the tunnel comprised of Phe22, Glu49, Asp60, Thr183, Gly211, Gly213, Gly234, and
Ser235 that are based on the 1qop sequence. -L6 residues 176-196 are in cyan. The
clinical F mutation at 253 is highlighted in green, and protein elongation in yellow.
Figure 5B shows the TrpA phylogenetic tree.
Recoverable infectivity of C. trachomatis clinical strains F I-IV was significantly
lower than for F/IC-Cal3 following tryptophan starvation and rescue. To assess
whether F I-IV can synthesize tryptophan from indole despite mutations in the 
subunits of the tryptophan operon, in vitro tryptophan starvation and indole rescue
assays were performed, comparing F I-IV and F/IC-Cal3 (see Materials and Methods). F
I-IV were not able to recover from tryptophan starvation using indole (Fig. 6A) at 48 h
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FIG 1 C. trachomatis clinical strains F I to IV (F I-IV) contain a trpA frameshift causing TrpA elongation. (A to
C) Partial nucleotide sequences showing trpR (A), trpB (B), and trpA (C) polymorphisms of the four serial
(Continued on next page)
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postinfection (hpi); these strains (IFN- –Trp indole) had significantly fewer
inclusion-forming units per milliliter (IFUs/ml) compared to the same strains receiving
media without IFN- (–IFN-) (P 0.01). Furthermore, when tryptophan was added
(–IFN- –Trp Trp), recoverable IFUs/ml were significantly higher than the starved
strains supplemented with indole (IFN- –Trp indole) (P 0.05). F/IC-Cal3 had an
overall higher growth rate in comparison to F I-IV for every condition (P 0.05). The
addition of indole to the tryptophan-depleted media (IFN- –Trp indole) was
sufficient to yield significantly higher IFUs/ml compared to IFN--treated F/IC-Cal3
(IFN-) (P 0.01).
To further evaluate the lack of recovery for F I-IV, inclusion morphology was
examined under IFN- and indole treatment (IFN- –Trp Indole) at 48 hpi. Clinical
F strain inclusions were considerably smaller (100 to 200 m2; Fig. 6C) than those
formed by F/IC-Cal3 (500 to 600 m2; Fig. 6B). In addition, under the same treatment
conditions, transmission electron microscopy (TEM) images showed that clinical strain
F II contained inclusion bodies with numerous aberrant bodies compared with F/IC-
Cal3 at 48 hpi (Fig. 6D and E). The morphology and TEM findings were similar for F I,
III, and IV (data not shown).
trpBA mRNA expression for clinical strains F I-IV was significantly reduced
compared to F/IC-Cal3 under tryptophan depletion and rescue. To verify F/IC-Cal3
tryptophan operon activity compared to F I-IV, trpBA mRNA expression levels were
measured at 24 and 48 hpi under the conditions of tryptophan starvation and rescue
with either indole or tryptophan (Fig. 7). At 24 hpi, during tryptophan starvation (–Trp)
and rescue with indole (–Trp Indole) or tryptophan (–Trp Trp), F/IC-Cal3 had
significantly higher expression levels of trpBA compared to F I-IV (Fig. 7). Additionally,
there was a trend in upregulation of F/IC-Cal3 trpBA expression when incubated in
tryptophan-depleted media (–Trp) compared with indole (–Trp Indole; P 0.0909)
and tryptophan supplementation (–Trp Trp; P 0.0736), indicating activity of the
tetrad during tryptophan starvation. trpBA levels were also measured at 12, 36, and 60
hpi; F/IC-Cal3 levels were upregulated starting at 12 hpi, whereas F I-IV trpBA levels
were relatively similar throughout development with 4.33-, 2.25-, and 3.16-fold lower
levels than F/IC-Cal3, respectively (data not shown). trpR expression levels showed a
similar trend, in which indole supplementation after tryptophan starvation was not
sufficient to downregulate trpR in clinical F strain (data not shown).
In vitro intracellular tryptophan concentrations vary significantly for reference
strain F/IC-Cal3 compared with clinical strains F I-IV. To determine whether F I-IV
can synthesize and utilize tryptophan following tryptophan starvation and indole or
tryptophan rescue, intracellular tryptophan concentrations were measured and com-
pared to those of F/IC-Cal3 (Fig. 8A and B). Using IFN- to deplete tryptophan, F I-IV had
significantly higher intracellular tryptophan concentrations than those of F/IC-Cal3
(P 0.0001; Fig. 8B) with a trend for tryptophan-depleted media (P 0.0559; Fig. 8A).
When tryptophan-depleted cultures were supplemented with indole, intracellular tryp-
tophan concentrations were significantly higher for F I-IV than for F/IC-Cal3 (Fig. 8A,
P 0.05; Fig. 8B, P 0.0001). These findings were supported by the higher levels of
intracellular tryptophan concentrations when tryptophan-depleted F I-IV cultures were
FIG 1 Legend (Continued)
clinical strains F I-IV compared to 20 C. trachomatis (Ct) reference strains (A/HAR13, Ba/Apache2, C/TW3,
D/UW3, Da/TW448, E/Bour, F/ICCal3, G/UW57, H/UW4, I/UW12, Ia/IU4168, J/UW36, Ja/UW92, K/UW31, L1/440,
L2/434, L2a/TW396, L2b/UCH-1/proctitis, L2c, and L3/404) including novel clinical F strains from the San
Francisco Bay Area (n 7) and all F strains previously sequenced and available from public databases
(n 59). A period in the sequence denotes homologous sequences that are not shown. Dashes denote
nucleotide deletions at positions A408, T409, T410, and T528 for trpA of ocular strains and at position 758 for
trpA of clinical strains F I-IV. Bold nucleotide letters denote substitution mutations, while bold amino acid
letters denote nonsynonymous amino acid substitutions. Strains with homologous sequences are not shown:
F/SotonF1-F4, F/Soton18-137, F/R4663-28312, F/STN15-22, F/UK35155-770010, F/SW4-5, F/SWFP, F/S1470-
3948, F/NI1, F/NL30-36, F/Aus20, F/C55, F/It686-688, F/Sou9-100, F/Swab5, F/SwabB5, F/Fin106-219, and
F/SF7-19. These strains had genes that were similar to the trpR gene of A/HAR13-L3/404, the trpB gene of
D/UW-3-K/UW-31, and the trpA gene of F/IC-Cal3-I/UW-12.
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supplemented with tryptophan compared to F/IC-Cal3 (Fig. 8A, P 0.01; Fig. 8B,
P 0.0001).
DISCUSSION
As an obligate intracellular bacterium and tryptophan auxotroph, Ct relies on host
tryptophan pools to replicate. However, despite the fact that Ct has a long history of
reductive evolution and loss of key functional enzymes (34), the organism has, by and
FIG 2 Phylogeny of trpRBA for 20 Ct reference strains, clinical F I-IV strains and other publicly available C. trachomatis F strains clustered F I-IV as a subbranch
of reference strain F/IC-Cal3. (A to C) trpR (A), trpB (B), and trpA (C) maximum likelihood trees were constructed using Tamura-3-parameters method with 10,000
bootstrap replicates of the F I-IV strains, seven novel clinical F strains collected from San Francisco Bay Area clinics, 59 Ct clinical F strains available from public
databases, and the 20 reference strains of Ct. B/UW-3 contained no trpRBA operon and therefore was not included. Scale bar at the top and at each branch
length correspond to sequence divergence scale and time. The numbers at branches indicate bootstrap score. Red dots, F I-IV strains; blue dots, San Francisco
F strains; magenta dots, reference Ct strains; green dots, ocular Ct strains; maroon dots, LGV strains.
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FIG 3 TrpA 3D predicted structures of clinical and reference C. trachomatis strains. (A to F) TrpA structures of Ct clinical
strains F I-IV (cyan) (A), elongation of clinical strain F 254N and 255L aa surface area (yellow) and -loop L6 (-L6) of
template 5tch (blue) and clinical strain F (cyan) (B), Ct urogenital reference strain F/IC-Cal3 (yellow) (C), -L6 of template
5tch (blue) and F/IC-Cal3 (yellow) (D), Ct ocular reference strain A/HAR13 (green) (E), and -L6 of template 5tch (blue) and
A/HAR13 (green, truncated) (F). All structures were constructed using the template from the published crystal structures
of the reconstructed putative last bacterial common ancestor (LBCA) tryptophan synthase 5ey5 (magenta) using MOD-
ELLER with visualization construction using Chimera (see Materials and Methods). Residues involved in both catalytic and
subunit interaction are shown in orange. Dashed lines represent the tunnel and substrate binding site at the  subunit.
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FIG 4 Comparative structure analyses of TrpB and TrpA for clinical strains F I-IV reveals mutations within the
functional  tetrad complex. (A to C) TrpA-TrpB dimer structures of Ct clinical strain F (cyan) (A), Ct urogenital
(Continued on next page)
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large, retained the tryptophan synthase operon. Previous in vitro studies have shown
that tryptophan depletion can drive Ct into a persistent form, yet with the addition of
indole or indole-producing bacteria to the media, urogenital but not ocular strains have
been able to synthesize tryptophan and complete their developmental cycle (25, 28).
Comparative genomics of Ct strains from different lineages have shown that the
ocular strains emerged from the urogenital strains around 10 to 15 million years ago
(29). Through subsequent reductive evolution, ocular strains lost their ability to syn-
thesize tryptophan. The low prevalence or lack of indole-producing bacteria in the
conjunctiva (35, 36) may have contributed to this loss. However, some indole producers
such as Propionibacterium acnes and Escherichia coli have routinely been found in the
microbiota of healthy conjunctiva (37). Others have proposed that ocular strains lost
their functional operon to maximize fitness (36). During infection and upregulation of
IFN-, Ct trpBA expression is induced, but in the absence of indole, the  subunit
catalyzes the deamination of L-serine to produce pyruvate and ammonia (38), an
antimicrobial agent that can also induce apoptosis of epithelial cells, especially under
higher pH levels (39), similar to those found on the ocular surface of healthy patients
(40). Losing tetramer function would prevent the production of this deleterious agent
and promote Ct growth. Sherchand and Aiyar recently demonstrated that indole
derivatives, produced by some gut bacteria and present in serum, can induce the
expression of Ct trpBA, despite sufficient tryptophan concentrations (41). They found
that these indole derivatives act as a derepressor of Ct TrpR, and during infection, when
indole is absent from the media, the ammonia produced by a functional tryptophan
synthase enzyme has bactericidal effects on Ct growth. This effect was absent when
ocular Ct strain A2497 or a urogenital D trpB-null strain with a point mutation in TrpB
was used (41).
In this study, we identified an F strain that was repeatedly isolated from the
endocervix of a woman with asymptomatic Ct infections. The F I-IV genomes were
100% identical, suggesting a persistent infection that was able to survive in spite of the
host immune response and repeated antibiotic treatment. The strains had a unique 
subunit point mutation that caused a frameshift and elongation of the TrpA by two aas
unlike any publicly available F strains. This is the first study to document a novel
urogenital Ct mutation in trpA with an in vivo advantage for a nonfunctional operon in
a clinical setting.
The clinical F TrpA 3D protein model showed that 254N and 255L at the C
terminus were not precisely located at the active ligand-binding site of indole. How-
ever, the G253D mutation replaced the nonpolar glycine with the acidic, negatively
charged aspartic acid near the active  subunit site and the 25-Å-long tunnel that
connects both subunits (Fig. 3B; dashed black line). Since the C-terminal residues for the
LBCA 5ey5,M. tuberculosis 5tch, and S. Typhimurium 1qop are basic, the surface polarity
change could alter the structural position and folding of residues in the tunnel (42, 43)
with functional consequences for the clinical F tryptophan synthase. Furthermore, while
the Ct TrpA cannot capture IGP to initiate indole production and does not produce
indole, indole is captured by the  subunit, and in other bacterial species, the tunnel
has been shown to accommodate indole channeling from the  subunit to the 
subunit (44).
The stability of the closed conformation depends on the  subunit movement of
-L6 and the allosteric connection between the  subunit glycine residue (Gly181)
and the  subunit serine residue (Ser178) (45). Interestingly, none of the Ct strains had
serine in this position; clinical F and F/IC-Cal3 had alanine, while A/HAR13 had leucine
FIG 4 Legend (Continued)
reference strain F/IC-Cal3 (yellow) (B), and Ct ocular reference strain A/HAR13 (green) (C). The TrpB structure is shown
with the -COMM domain in black. All TrpA and TrpB structures were constructed using the template from the
published crystal structures of the reconstructed putative last bacterial common ancestor (LBCA) tryptophan synthase
5ey5 (magenta) using MODELLER with visualization construction using Chimera (see Materials and Methods). -L6
residues are shown in blue, and residues involved in both catalytic and subunit interaction are shown in orange.
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FIG 5 TrpA amino acid alignment and phylogeny of C. trachomatis clinical strains F I-IV, A/HAR13, F/IC-Cal3, and
Protein Data Bank (PDB) templates. (A) For 3D model reconstructions, amino acid alignments of Ct clinical
(Continued on next page)
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(Fig. 5A). This suggests that Ct tetramer function may be somewhat compromised, even
for strains with the complete sequence like F/IC-Cal3, and thus inefficient at producing
tryptophan. The A/HAR13 TrpA model revealed a truncated protein in the middle of
-L6, explaining the inability of this strain and other truncated strains to form a closed
conformational state to capture indole. The allosteric effect between the two subunits
is essential to the efficiency of the enzyme and is different among various bacteria. Ct
TrpB was found to be inactive in the absence of a full-length TrpA (24). In E. coli, while
the  subunit is capable of functioning by itself to produce tryptophan from indole,
when it is in an  configuration or in its physiological complex, the allosteric effect
enhances the catalytic efficiency. Surprisingly, in contrast to E. coli, the LBCA  subunit
was found to have a fivefold reduction in the catalytic efficiency when it was found in
a complex (32). Although the tryptophan synthase enzyme from the LBCA had the
highest homology to the enzyme from Ct, the allosteric effect between the two
subunits was distinct.
Not surprisingly, when clinical F strains were deprived of tryptophan by IFN-
treatment, they were not able to recover with indole supplementation, similar to ocular
strains. When tryptophan was added back to the starved clinical F strains (IFN- –Trp
Trp), recoverable IFUs/ml were significantly higher than the tryptophan-starved
clinical strains growing in the presence of indole. F/IC-Cal3 had an overall higher
growth rate in comparison to the clinical strains, and the addition of indole or
tryptophan yielded significantly higher IFUs/ml. These data are supported by the fact
that clinical F strains produced significantly smaller inclusions than F/IC-Cal3 under
IFN--induced tryptophan starvation and indole supplementation (Fig. 6). Furthermore,
under the same conditions, the clinical F strains contained many aberrant bodies in the
inclusions with few mature infectious elementary bodies (EBs) compared to F/IC-Cal3.
These collective data indicate the lack of a functional tryptophan synthase for the
clinical F strains.
To assess the ability of clinical F strains to regulate trpRBA in a transcriptional
manner, mRNA expression levels of trpBA were measured during tryptophan starvation
with subsequent indole and tryptophan rescue. Consistent with previous work using
reference Ct strains with and without functional tryptophan operons (25, 46), we found
that at 24 hpi during tryptophan starvation, F/IC-Cal3 had significantly higher expres-
sion levels of trpBA compared with the clinical F strains, indicating that the latter strains
cannot upregulate trpBA expression and therefore are not capable of synthesizing
tryptophan efficiently. This conclusion is supported by our findings that clinical F strain
trpBA expression levels were relatively similar, regardless of treatment conditions,
throughout development at 12, 24, 36, 48, and 60 hpi compared to F/IC-Cal3. Tran-
scription of trpBA might also be influenced by additional factors. Recent work has
shown that the iron-dependent transcription factor, YtgR, can bind to the intergenic
region (IGR) between trpR and trpB, regulating the expression of the operon (47).
Although the clinical F IGR and YtgR transcription factor are similar to those of F/IC-Cal3
(not shown), perhaps additional factors influence the operator near or within the 
tetramer.
Because Ct scavenges host tryptophan pools during tryptophan scarcity, intracellu-
lar tryptophan concentration decreases due to competition between the organism and
host cell (48). We found that when tryptophan was depleted by IFN- treatment or
tryptophan-depleted media, clinical F strains had higher intracellular tryptophan con-
FIG 5 Legend (Continued)
strains F/I-IV, F/IC-Cal3, and A/HAR13 with the PDB templates of LBCA 5ey5, M. tuberculosis 5tch, and S.
Typhimirium 1qopA was performed using Clustal Omega (see Materials and Methods). Residues involved in
both catalytic and subunit interaction (magenta), -L6 residues 176-196 according to the 5tch sequence
(cyan), clinical strain F mutation G253D and .254N and .255L aa elongation (yellow), gray, basic amino acids
arginine and lysine in template sequences (gray), and acidic amino acid aspartic acid in clinical strains (green)
are indicated. (B) Phylogenetic tree of Ct strains and PDB aa templates using neighbor joining with Jones-
Taylor-Thornton (JTT) substitution method with 10,000 bootstrap replications using MEGA 7 (see Materials and
Methods).
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FIG 6 Recoverable infectivity of C. trachomatis clinical strains F I-IV was significantly lower than for F/IC-Cal3
following tryptophan starvation and rescue. Infected cells were incubated for 48 h in the presence of either
complete DMEM medium (–IFN-), tryptophan-free DMEM medium treated with 5 ng/ml human IFN- (IFN-),
tryptophan-free DMEM medium treated with 5 ng/ml human IFN- supplemented with 50 M Indole (IFN- –Trp
Indole) or 10 mg/liter tryptophan (IFN- –Trp Trp). (A) Comparison between reference strain F/IC-Cal3 and
clinical strains F I-IV. Mean recoverable IFUs/ml plus standard deviations (SD) (error bars) from three independent
experiments. †, P 0.0597; *, P 0.05; **, P 0.01; ****, P 0.0001. (B) Inclusion morphology of F/IC-Cal3 under
IFN- and indole treatment (IFN- –Trp Indole). Inclusions were stained with a FITC-conjugated Ct-specific LPS
MAb (see Materials and Methods). White arrowheads indicate Ct inclusions. (C) Clinical strain F II under IFN- and
indole treatment (IFN- –Trp Indole); inclusions were stained with a Ct-specific LPS-MAb at 48 hpi. The
morphology of F I, III, and IV were similar to that of F II (data not shown). Arrowheads indicate Ct inclusions. (D)
TEM of clinical strain F II and (E) reference strain F/IC-Cal3 under IFN- and indole treatment (IFN- –TrpIndole)
at 48 hpi. White arrow, Elementary Body; Black arrow, Intermediate Body; white arrowhead, Reticulate Body; black
arrowhead, Aberrant Body.
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centrations compared to F/IC-Cal3, suggesting that F/IC-Cal3 is a stronger competitor
at utilizing host tryptophan pools to recover from starvation. When tryptophan-
depleted cultures were supplemented with indole, the findings were similar, indicating
that F/IC-Cal3 was more efficient at utilizing indole for tryptophan synthesis that in turn
was more efficiently metabolized for recovery. These findings were supported by the
higher levels of intracellular tryptophan concentrations for the clinical F strains when
the cultures were supplemented with tryptophan.
Ct is thought to enter a persistent form when tryptophan is depleted by the host
immune response, thereby decreasing its metabolic rate to survive (reviewed in refer-
ence 49). However, the organism may first scavenge host tryptophan reservoirs to
continue its developmental cycle. The risk with the latter scenario is that low trypto-
phan concentrations in epithelial cells and the surrounding environment may lead to
cellular apoptosis (50). Alternatively, entering a persistent state shortly after tryptophan
is limited would preserve host cell tryptophan pools as well as provide a protective
niche inside the cell for survival. The clinical F strains that we isolated from the same
woman resemble the benefits of this Ct persistent form during stressful conditions that
include repeated antibiotic treatment and nutrient deficiency induced by the host
immune response. Resurgence of the infection may have occurred when sufficient
tryptophan became available.
Ct could have evolved from an ancestor that was initially residing in the gastroin-
testinal tract (51) where high levels of indole are available. The availability of indole may
have also facilitated establishment of the urogenital tract as another tropic site for Ct
infection. Although the ability to utilize indole is considered an advantage for this
obligate intracellular pathogen, perhaps the loss of a functional  subunit through
evolution as for the ocular strains has benefited survival. One part of this may be the
energy cost savings in not having to synthesize tryptophan. In any case, it appears that
we are now starting to see clinical benefit for this loss of function in sexually trans-
mitted strains.
Although mutations in trpA that result in a dysfunctional tryptophan operon were
thought to be confined only to ocular strains, the discovery of other mutations among
F strains in the present study suggests an additional key evolutionary strategy that
allows the organism to survive likely via persistence, even when indole is present. Our
FIG 7 trpBA mRNA expression levels for clinical strains F I-IV were significantly reduced compared to
F/IC-Cal3 under tryptophan depletion and rescue. At 48 h before infection, HeLa cells were treated with
5 ng/ml of human IFN- for 24 h in tryptophan-free media. Infected cells were incubated in the presence
of either tryptophan-free DMEM (–Trp), tryptophan-free DMEM supplemented with 100 M indole (–Trp
Indole), or tryptophan-free DMEM supplemented with 10 mg/liter tryptophan (–Trp Trp). Infected
cells were harvested at indicated times. RNA was reversed transcribed to cDNA, and expression levels
were normalized to the Ct 16S rRNA and presented as means plus SD from three independent
experiments. Data are shown for F I, although F II-IV had similar mRNA transcription patterns. There were
no statistically significant differences at 48 hpi. *, P 0.05.
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data indicate that these mutations affected the structure of the  tetramer and,
thereby, impact the regulation and function of the operon for the synthesis of trypto-
phan from indole. Furthermore, this study supports the notion that, during IFN--
induced IDO activity and depletion of tryptophan, clinical urogenital Ct strains can
develop persistent infections in vivo. These strains may periodically be able to cause an
active infection when tryptophan becomes available, perhaps explaining the recur-
rence of infections over many years for the patient in our study.
MATERIALS AND METHODS
Sample collection, C. trachomatis clinical strain isolation, and whole-genome sequencing.
Endocervical flock swabs (Copan, Murrieta, CA) were collected from women attending health clinics in
the San Francisco Bay Area as part of a larger study and were supplied deidentified with no trace to the
patient’s name. Hence, the institutional review board (IRB) at University of California San Francisco
Benioff Children’s Hospital Oakland determined that this research does not involve human subjects.
Swab samples were placed in cryovials containing 1 ml of M4 medium (Thermo-Fisher, Waltham, MA)
and kept at80°C until processed. C. trachomatis (Ct) was isolated from a female with four chronological
(4 years) STIs who had been treated with doxycycline or azithromycin for each documented infection.
Ct was isolated as previously described (52). Briefly, at 48 hpi, infected cells were harvested, propagated,
and purified by density gradient centrifugation as previously described (52). Genomic DNA was purified
from each isolate, termed F I, F II, F III, and F IV, with subsequent whole-genome sequencing as we
described previously (29). ompA and trpRBA were resequenced for verification as described previously
(52). Table S1 in the supplemental material lists the primers used in this study.
Phylogeny of C. trachomatis clinical strains F I-IV trpRBA and TrpRBA. trpRBA and TrpRBA
sequences from the four isolates F I to IV (F I-IV) were compared for nucleotide (nt) and amino acid (aa)
FIG 8 In vitro intracellular tryptophan concentrations vary significantly for reference strain F/IC-Cal3
compared with clinical strains F I-IV. (A and B) Ct-infected HeLa cells were incubated with either
tryptophan-free DMEM medium (Trp) (A) or complete medium treated with IFN- (IFN-) (B) (see
Materials and Methods). The medium was supplemented with indole (Trp Indole or IFN- Indole)
or tryptophan (Trp Trp or IFN- Trp) as indicated. Infected cells were harvested at 48 hpi, and
intracellular tryptophan concentrations were measured using high-pressure liquid chromatography-
linked tandem mass spectrometry (see Materials and Methods). Data are presented as the mean
tryptophan concentration (in picomoles) normalized to Ct 16S rRNA plus SD based on two independent
experiments. *, P 0.05; **, P 0.01; ****, P 0.0001.
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differences using MEGA 7 (https://mafft.cbrc.jp/alignment/software/). Sequences from seven San Fran-
cisco Bay Area clinical F strains and 59 F strains from all public databases were aligned with F I-IV and
20 Ct reference strains (Fig. 1, Fig. 2). Maximum likelihood trees were constructed as previously described
(29) with 10,000 bootstrap replicates. For aa phylogenies, maximum likelihood trees were constructed
using Jones-Taylor-Thornton (JTT) substitution model with 500 bootstrap replicates. Ct TrpA and TrpB
were also aligned with homologs from other organisms using neighbor joining to detect significant
subfamily conserved residues that may be evolutionarily related (29).
Comparative TrpA and TrpB structure analyses of C. trachomatis clinical and reference strains
with homologous species. F I-IV, F/IC-Cal3, and A/HAR13 TrpA and TrpB sequences were uploaded to
MODBASE (http://salilab.org/modbase), and comparative protein three-dimensional modeling structures
were calculated using MODELLER (53) with pairwise sequence alignment, sequence-sequence, sequence-
profile, and PSI-BLAST methods (54). CHIMERA was used for structural visualization (55). Protein struc-
tures were analyzed by satisfaction of spatial restraint (56). The reconstructed putative LBCA tryptophan
synthase 5ey5 had the highest homology to Ct  and  subunits, followed by M. tuberculosis 5tch and
S. Typhimurium 1qop. Ct sequences were aligned with 5ey5, 5tch, and 1qop using Multalign-Viewer
extension (57) and Clustal Omega (58). Ct TrpA models were then generated based on the 5ey5 protein
structure (homology score of 32.16% to F I-IV, 34.43% [based on 183 aa] to A/HAR13 and 32.02% to
F/IC-Cal3). Ct TrpB models were similarly based on 5ey5 with 56.12% homology to F I-IV and F/IC-Cal3
and 55.87% to A/HAR13.
To authenticate MODELLER structure and functional residue predictions, TrpA domain architectures
were determined using Conserved Domain (CD) (59), Protein family (Pfam) (60), Simple Modular
Architecture Research Tool (SMART) (61), Transmembrane helix prediction (TMHMM) (62), and SignalP
(63) tools. Protein BLAST (64) against the Protein Data Bank (PDB) using a 0.01 cutoff E value and Protein
Homology/analogy Recognition Engine (Phyre) (65) were performed to obtain additional homologs that
could represent the F I-IV TrpA structure.
Ct putative active ligand-binding sites, the indole tunnel, TrpA-TrpB communication (COMM) domain,
and nonsynonymous mutations were manually identified and visualized on the predicted models, based
on previous work and crystal structures of different Escherichia coli and S. Typhimurium mutants (24,
43–45, 66–68).
C. trachomatis in vitro tryptophan starvation and rescue assays. HeLa229 cell monolayers were
inoculated with F I-IV or F/IC-Cal3 at a multiplicity of infection (MOI) of 3. For recoverable infectivity
assays, inoculates were incubated in either complete Dulbecco modified Eagle medium (DMEM)
(Thermo-Fisher) (–IFN-), tryptophan-free DMEM treated with 5 ng/ml human IFN- (IFN-) (Sigma-
Aldrich), tryptophan-free DMEM with 5 ng/ml human IFN- supplemented with 50 M indole (IFN-
–Trp Indole) (Sigma-Aldrich), or 10 mg/liter tryptophan (IFN- –Trp Trp). For trpBA mRNA transcrip-
tion assays, inoculates were incubated in either tryptophan-free DMEM (–Trp), tryptophan-free DMEM
supplemented with 100 M indole (–Trp Indole) or tryptophan-free DMEM supplemented with 10 mg/
liter tryptophan (–Trp Trp). For intracellular tryptophan concentrations, inoculates were incubated in
tryptophan-free DMEM, DMEM supplemented with 100 M indole, DMEM supplemented with 10 mg/
liter tryptophan, or with complete CMGH medium supplemented with IFN- alone (IFN-), IFN- and
indole (IFN-Indole), or IFN- and tryptophan (IFN-Trp). Cultures were incubated for 24 or 48 h
(37°C, 5% CO2) as indicated.
Recoverable infectious progeny of C. trachomatis clinical strains F I-IV compared to reference
strain F/IC-Cal3 following tryptophan starvation and rescue. The initial infected cultures were used
to infect fresh HeLa cell monolayers, incubated for 44 to 48 h, fixed with methanol, and stained using
fluorescein isothiocyanate (FITC)-conjugated Ct-specific lipopolysaccharide (LPS) monoclonal antibody
(Mab) (Virostat, Westbrook, ME) and Hoechst (to detect nuclei) for enumerating inclusion-forming units
per milliliter (IFUs/ml) as we described previously (69).
Microscopy and transmission electron microscopy. Morphological characteristics in cell culture
were evaluated with fluorescence and transmission electron microscopy (TEM) over the course of in vitro
development. At 48 hpi, coverslips were fixed and stained, and IFUs/ml were enumerated as described
above. Imaris X64 software was used to calculate inclusion area as square micrometers as we described
previously (69).
Infected cultures were harvested for TEM characterization as we described previously (69). Briefly,
wells were washed with phosphate-buffered saline (PBS) (Mediatech, Herndon, VA) containing 2%
glutaraldehyde in 0.1 M sodium cacodylate (Electron Microscope Lab [EML] at University of California
[UC] Berkeley), pelleted at 200 g, and prefixed in 2% glutaraldehyde in 0.1 M sodium cacodylate. The
samples were refrigerated at 4°C for 24 h prior to postfixation with 1% osmium tetroxide in 0.1 M sodium
cacodylate and washed in 0.1 M sodium cacodylate buffer and 0.5% aqueous uranyl acetate overnight.
Cells were dehydrated using a graduated ethanol series, embedded in Epon-Araldite resin, and allowed
to polymerize. A Riechert Ultracut MT6000 microtome was used to slice 60- to 90-nm sections prior to
staining with 2% uranyl acetate and Reynolds lead citrate. A Tecnai 12 TEM (EML) was used for imaging.
mRNA expression of trpR and trpBA following tryptophan starvation and rescue. By using an
MOI of 3, 100% of the cells were infected. Infected cells were incubated as described above and
harvested at 24 and 48 hpi (69). Briefly, total RNA was extracted and reverse transcribed to cDNA and
subjected to quantitative reverse transcription-PCR (qRT-PCR) with two replicates of each cDNA sample
and control. 16S rRNA gene expression was used as a control for the number of Ct organisms; the human
-actin gene was used as a control for host cell viability. Normalization of the 16S rRNA gene to -actin
gene was used for relative Ct growth.
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Intracellular tryptophan concentrations. At 48 hpi, infected cells were pelleted and resuspended
in perchloric acid (Sigma-Aldrich) (10% wt/vol) solution containing 1 mM diethylenetriamine pentaac-
etate (Sigma-Aldrich) for cell lysis, followed by 4°C centrifugation at 1,500 rpm. Tryptophan concentra-
tions were measured in supernatants using high-performance liquid chromatography-linked tandem
mass spectrometry (HPLC-MS/MS) with the EZ-FAAST aa derivatization kit (Phenomenex, Torrance, CA) as
previously described (70). Briefly, supernatants containing tryptophan were mixed with an internal
standard (tyrosine 3,3-D2), and pellets were mixed with a strong cation exchange resin (Phenomenex,
Torrance, CA). Derivatization was performed using the manufacturer’s protocols. Derivative products
were extracted with isooctane (Sigma-Aldrich), dried under nitrogen, and reconstituted with a mobile
phase. Analytes were quantified based on purified standard compounds. Data were normalized against
Ct 16S rRNA gene transcription levels.
Statistical analysis. Data were analyzed using Prism GraphPad V.6. Statistical significance was
determined using two-way analysis of variance (ANOVA); P values were calculated using Tukey’s
multiple-comparison test. A P value of 0.05 was considered significant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01464-19.
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